Chatzikyriakou, Prodromos
Brempou, Dimitria
Quinn, Mark
Fishbein, Lauren
Noberini, Roberta
Anastopoulos, Ioannis N.
Tufton, Nicola
Lim, Eugenie S.
Obholzer, Rupert
Hubbard, Johnathan G.
Moonim, Mufaddal
Bonaldi, Tiziana
Nathanson, Katherine L.
Izatt, Louise
Oakey, Rebecca J.
Funding for this research was provided by:
Bernice Bibby Research Trust
National Institute for Health and Care Research
King's College London
Horizon 2020 Framework Programme (823839, 823839)
GlaxoSmithKline
Associazione Italiana per la Ricerca sul Cancro (IG-2018-21834, IG-2018-21834)
The Medical College of St. Bartholomew’s Hospital Trust, United Kingdom
Barts Charity (MGU0468)
Medical Research Council (MR/W001101/1)
National Institutes of Health (CA185953)
Wellcome Trust (212917/Z/18/Z)
Article History
Received: 17 July 2023
Accepted: 8 November 2023
First Online: 20 December 2023
Declarations
:
: All human samples and associated clinical data were obtained after written informed consent to participate in the study and be included in the data for publication, adhering to the appropriate laws and ethical principles of the Declaration of Helsinki (REC 17/SW/0018 for UK PPGL samples, 06/Q0104/133 for UK normal adrenal medulla samples, and IRB 812495 approved by the University of Pennsylvania IRB for patient samples from the USA study).
: The authors declare no competing interests.